BAPTIST MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $10.2M
- Transactions
- 1,533
- Companies
- 40
- Average per transaction
- $6,638
Who reported the payments
| Merck | $4,079,086 |
| Seagen Inc. | $1,023,828 |
| AbbVie | $664,748 |
| Roche Products Limited | $415,999 |
| E.r. Squibb & Sons, L.L.C. | $398,321 |
| Novartis | $338,397 |
| Clovis Oncology, Inc. | $336,679 |
| Genentech, Inc. | $255,028 |
| ADC Therapeutics America, Inc. | $237,381 |
| Route 92 Medical, Inc. | $181,952 |
| Elekta Instrument AB | $141,000 |
| Stryker | $132,240 |
| Janssen Research & Development, LLC | $122,774 |
| Johnson & Johnson | $112,786 |
| Sirtex Medical Inc | $109,523 |
| Daiichi Sankyo Inc. | $109,105 |
| Rapid Medical Ltd | $107,481 |
| Otsuka Pharmaceutical Co., Ltd. | $98,929 |
| Acutus Medical, Inc. | $95,000 |
| Medtronic | $89,006 |
| Hoffmann-la Roche Limited | $85,472 |
| Novocure GmbH | $79,810 |
| Bristol Myers Squibb | $78,297 |
| Amgen | $69,412 |
| Gilead | $57,175 |
| Incyte Corporation | $47,421 |
| Pfizer | $46,901 |
| Pharmaessentia USA Corporation | $44,500 |
| Imperative Care, Inc | $44,050 |
| Beigene, Ltd. | $40,546 |
| Immunogen, Inc. | $35,743 |
| Morphosys AG | $34,250 |
| Vektor Medical Inc. | $32,584 |
| GE HealthCare | $28,451 |
| Takeda Pharmaceuticals U.S.A., Inc. | $27,761 |
| Pharmaand GmbH | $25,120 |
| GT Medical Technologies, Inc | $24,400 |
| Carl Zeiss Meditec, Inc. | $24,164 |
| Angiodynamics, Inc. | $23,333 |
| Insulet Corporation | $22,800 |